Remdesivir modifies interferon response in hospitalized COVID-19 patients - 13/10/22


Highlights |
• | Remdesivir downregulates interferon responses in hospitalized COVID-19 patients. |
• | Treatment had a particularly strong effect on interferon γ. |
• | This response could be beneficial in mild, but not in severe disease. |
• | Treatment options in COVID-19 could differ according to disease severity. |
Plan
Vol 85 - N° 5
P. 573-607 - novembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.